• Uptravi Beneficial Regardless of When Started, But More Effective if Started Early, Analysis Suggests
  • Balloon Pulmonary Angioplasty Reduces Sleep Apnea in Patients with CTEPH, Study Shows
  • Resverlogix Announces Promising Findings on Apabetalone, Will Launch Phase 2 Trial in PAH Patients
  • Rare Diseases Constitute a ‘Public Health Issue,’ NCATS Director Warns
  • Clinical Development of INOpulse for PH Continues to Move Forward, Bellerophon Reports
  • Balloon Pulmonary Angioplasty Can Improve Survival of Patients with Inoperable CTEPH, Study Suggests
  • Pain Makes Me Lose the ‘Real Me’ and I Don’t Like the Person I Become
  • Mallinckrodt’s INOmax Improves Oxygenation of Newborns with PH, Interim Study Analysis Shows
  • Herbal Compound Silibinin Eases Early Signs of PAH in Rats, Study Shows
  • Teva Launches Generic Version of PAH Therapy Letairis in US
  • The Waiting Is the Hardest Part: Anticipation Heightens My Anxiety
  • PALS Uplifts the Spirits of Rare-Disease Patients by Offering Free Flights